See Article, pages [874] [875] [876] [877] [878] [879] [880] [881] [882] [883] [884] Pathophysiological descriptions of amyotrophic lateral sclerosis (ALS) have broadened in recent years to include recognition of widespread involvement of brain pathways in the 'connectome', including corpus callosum, with degenerative neuronal pathology in associated cortical areas, basal ganglia, brainstem, cerebellum and spinal cord. In general, these pathological changes are in the anterior brain and its connections, and thus in the classical motor and also in the emotionally expressive brain, including frontal lobes anterior to primary motor areas and temporal lobes. However, perhaps unexpectedly, there is also prominent involvement of ascending sensory pathways, most notably the spinocerebellar pathways that ascend to Clarke's nucleus in the upper brain stem before projecting to pontine and medullary systems and thence into cerebellar nuclei, basal ganglia and cortex (Swash et al., 1988) . Although long recognized in pathological studies (for example, Brownell et al., 1970) , the importance of these central nervous system (CNS) abnormalities is now accessible by MR imaging, using fractional anisotropy, which has disclosed such changes even in the early stages of the disease. At the spinal level in ALS there are abnormalities in the organization of sensory-motor connections in the anterior grey matter of the cord, including degeneration of interneurons and gamma motor neurons, abnormalities that correlate with the frequent relative absence of upper motor neuron signs (Swash, 2012) . Further, the classical spinal pathology, as in the Weigert-Pal method for myelinated axons, sometimes includes not only degenerative pallor of spinocerebellar pathways but also of the medial component of the posterior columns and loss of neurons in Clarke's nucleus. It is also relevant to note that in whole, teased, silver or gold chloride impregnated, preparations of muscle spindles in small hand muscles obtained at autopsy in ALS, the muscle spindle primary and secondary sensory endings are histologically normal, but the gamma and beta motor innervations in these spindles are both destroyed (Swash and Fox, 1974) . The sensory innervation of Golgi tendon organs is also histologically normal. In ALS, the CNS is therefore presumed to be unable to modulate the sensitivity of muscle spindles to changes in stretch, although this has not been studied directly.
Clinical studies of the sensory system in ALS have suggested a subtle abnormality undetectable to ordinary clinical examination but demonstrable in quantitative sensory studies. For example, changes have been reported in sensory thresholds to vibration, cutaneous (Mulder et al., 1983) and warm stimulation (Jamal et al., 1985) , and also in sensory nerve action potentials, that develop during the course of the disease. In addition, a reduction in the duration of post-ischemic paraesthesia in peripheral nerve has been described (Shahani and Russell, 1969) . These abnormalities are perhaps consistent with the neglected observation of partial loss of cutaneous afferent nerve fibers found in nerve biopsy studies in ALS (Kawamura et al., 1981) and with the pathological changes noted in the spinocerebellar and, to a lesser extent, in dorsal column afferents in the cord. The advent of sensory evoked potential (SEP) studies in the 1970s facilitated more detailed investigation of the sensory system in ALS but, as Sangari et al. (2018) note in their report in this issue of Clinical Neurophysiology, these studies largely concentrated on the early SEP components and, indeed, reported somewhat conflicting results, possibly due to undetected peripheral sensory axon loss. The early N9 SEP reflects the afferent volley at brachial plexus, and the later N20, P25, N30 and P35 peaks derive from activation of sensory and motor cortex. The even later components of the SEP are thought to arise in secondary somatosensory and association cortical areas, with contributions from deep grey matter nuclei. Sangari et al. (2018) now report greater depression of late SEP components in ALS than of the early SEP components. They noted a non-linear correlation between changes in N20, P25 and N30, but not between P25, N30, N60 and P100. They conclude that their findings suggest abnormal sensorimotor integration, as shown by the later SEP results, not explicable by any subtle primary abnormality in sensory input to the CNS. They did not explore quantitative sensory testing in their patient group, but cite their earlier work (Iglesias et al., 2015) as revealing correlation between changes in diffusion MRI in the posterior columns of the cord and depression of N9, but emphasizing a lack of correlation between this depression of N9 and the amplitude of N20. They interpret their findings as evidence of functional change in sensory and connected motor pathways in the brain in ALS. These concepts are consistent with the post mortem pathology of the disease and with contemporary MRI studies (Verstraete et al., 2015) . The clinical and physiological features of the disease are also consistent with abnormalities in sensorimotor connections in the anterior horns of the spinal cord. This disorder of sensorimotor integration in the disease has only come to attention relatively recently, with the advent of MR imaging, despite the wealth of evidence in the older literature.
In clinical practice, there is a long-standing and continuing dif- 
